Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2017
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health SystemsMei Lu, Jia Li, Irina V Haller, et al.Clinical Epidemiology|November 18, 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary CholangitisMei Lu, Christopher L Bowlus, Keith Lindor, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With TreatmentMei Lu, Yueren Zhou, Irina V Haller, et al.The American Journal of Gastroenterology|January 28, 2020
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary CholangitisStuart C Gordon, Kuan-Han Hank Wu, Keith Lindor, et al.Digestive Diseases and Sciences|September 9, 2021
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USAJia Li, Mei Lu, Yueren Zhou, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.Journal of Viral Hepatitis|June 20, 2026
HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis DDimitra Lakiotaki, Margarita Papatheodoridi, Vasilios Sevastianos, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis DMargarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, et al.Pageof 11